Copyright
©The Author(s) 2020.
World J Gastroenterol. Aug 28, 2020; 26(32): 4878-4888
Published online Aug 28, 2020. doi: 10.3748/wjg.v26.i32.4878
Published online Aug 28, 2020. doi: 10.3748/wjg.v26.i32.4878
Patient ID | OraQuick® | anti-HCV | Anti-HCV levels |
84 | Positive | ||
195 | Positive | ||
263 | Positive | Positive | 11 < |
267 | Positive | Positive | 11 < |
333 | Positive | ||
348 | Positive | Positive | 11 < |
373 | Positive | Positive | 11 < |
374 | Positive | Positive | 11 < |
410 | Positive | Positive | 11 < |
413 | Negative | Positive | 1.35 |
422 | Negative | Positive | 9.67 |
424 | Positive | Positive | 11 < |
426 | Positive | ||
428 | Positive | Positive | 11 < |
435 | Positive | ||
490 | Positive | 11 < | |
515 | Positive | 11 < |
- Citation: Houri I, Horowitz N, Katchman H, Weksler Y, Miller O, Deutsch L, Shibolet O. Emergency department targeted screening for hepatitis C does not improve linkage to care. World J Gastroenterol 2020; 26(32): 4878-4888
- URL: https://www.wjgnet.com/1007-9327/full/v26/i32/4878.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i32.4878